ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Three Nurse Awards Made In Self Care

September 30, 1988

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

In Brief: Registration Deadlines Coming Up For 13th Cancer Congress; Breast Cancer Meeting Postponed To ‘83

May 28, 1982

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

In Brief: Wittes DCT Acting Deputy Director; Spallone Leaves For Fox Chase; Ronald Evens Heads AUR

June 24, 1988